Enfusion, Inc.
(NYSE: ENFN)
Rigrodsky Law, P.A. is investigating Enfusion, Inc. (“Enfusion”) regarding possible breaches of fiduciary duties and other violations of law related to Enfusion’s agreement to be acquired by Clearwater Analytics. Under the terms of the agreement, Enfusion shareholders will receive $5.85 per share in cash.